FRA
Front Row Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.58K | Sell |
3
-1
| -25% | -$525 | ﹤0.01% | 482 |
|
|
2025
Q1 | $2.54K | Hold |
4
| – | – | ﹤0.01% | 442 |
|
|
2024
Q4 | $2.85K | Hold |
4
| – | – | ﹤0.01% | 430 |
|
|
2024
Q3 | $4.21K | Hold |
4
| – | – | ﹤0.01% | 417 |
|
|
2024
Q2 | $4.2K | Hold |
4
| – | – | ﹤0.01% | 759 |
|
|
2024
Q1 | $3.85K | Hold |
4
| – | – | ﹤0.01% | 768 |
|
|
2023
Q4 | $3.51K | Hold |
4
| – | – | ﹤0.01% | 393 |
|
|
2023
Q3 | $3.29K | Hold |
4
| – | – | ﹤0.01% | 750 |
|
|
2023
Q2 | $3K | Hold |
4
| – | – | ﹤0.01% | 770 |
|
|
2023
Q1 | $3K | Buy |
+4
| New | +$3K | ﹤0.01% | 780 |
|
|
2022
Q4 | – | Sell |
-4
| Closed | -$3K | – | 932 |
|
|
2022
Q3 | $3K | Hold |
4
| – | – | ﹤0.01% | 765 |
|
|
2022
Q2 | $2K | Hold |
4
| – | – | ﹤0.01% | 840 |
|
|
2022
Q1 | $3K | Hold |
4
| – | – | ﹤0.01% | 816 |
|
|
2021
Q4 | $3K | Hold |
4
| – | – | ﹤0.01% | 841 |
|
|
2021
Q3 | $2K | Hold |
4
| – | – | ﹤0.01% | 875 |
|
|
2021
Q2 | $3K | Hold |
4
| – | – | ﹤0.01% | 833 |
|
|
2021
Q1 | $2K | Sell |
4
-31
| -89% | -$15.5K | ﹤0.01% | 876 |
|
|
2020
Q4 | $17K | Hold |
35
| – | – | 0.01% | 412 |
|
|
2020
Q3 | $18K | Hold |
35
| – | – | 0.01% | 393 |
|
|
2020
Q2 | $22K | Sell |
35
-1
| -3% | -$629 | 0.01% | 330 |
|
|
2020
Q1 | $19K | Sell |
36
-2
| -5% | -$1.06K | 0.01% | 342 |
|
|
2019
Q4 | $14K | Hold |
38
| – | – | 0.01% | 394 |
|
|
2019
Q3 | $11K | Buy |
38
+4
| +12% | +$1.16K | 0.01% | 424 |
|
|
2019
Q2 | $11K | Sell |
34
-3
| -8% | -$971 | 0.01% | 422 |
|
|
2019
Q1 | $15K | Buy |
37
+4
| +12% | +$1.62K | 0.01% | 381 |
|
|
2018
Q4 | $12K | Hold |
33
| – | – | 0.01% | 373 |
|
|
2018
Q3 | $12 | Hold |
33
| – | – | 0.01% | 398 |
|
|
2018
Q2 | $12 | Buy |
33
+6
| +22% | +$2 | 0.01% | 422 |
|
|
2018
Q1 | $9K | Buy |
+27
| New | +$9K | 0.01% | 457 |
|